A Pilot Study of Eicosapentaenoic Acid (EPA) in Patients With Cancer Cachexia

NCT00815685 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

36

Enrollment

OTHER

Sponsor class

Conditions

Cancer Cachexia

Interventions

DRUG: Eicosapentaenoic Acid

Sponsor

H. Lee Moffitt Cancer Center and Research Institute

Collaborators

[object Object]